Page 2446

(1) contacting the prescriber or prescriber’s representative; and

(2) documenting on the prescription form

(A) the name of the prescriber or prescriber’s representative who verified the prescription; and

(B) the date the prescription was verified. (h) Failure to comply with (a) — (g) of this section may result in a finding of an overpayment that may be recouped by the department during pre- or postpayment audit or review. (Eff. 5/18/2014, Register 210) Statutory Authority: Authority: AS 47.05.010 AS 47.07.030 AS 47.07.040 7 AAC 120.120. Drug use review. (a) The purpose of this section is to establish a drug use review program to comply with the requirements of 42 U.S.C. 1396r-8(g). The drug use review program primarily consists of prospective drug use review, retrospective drug use review, and educational outreach. The purpose of drug use review is to screen for potential drug therapy problems, identify and prevent abuse of prescribed drugs, and prevent inappropriate or unnecessary drug use. This section applies only to the prescription and dispensing of a drug provided to a Medicaid recipient who is not a recipient in a hospital or nursing facility. (b) As part of the prospective drug use review required in (a) of this section, and before the department will pay a pharmacy, a pharmacist shall make a reasonable effort to review a recipient’s drug therapy before a prescription is delivered to the recipient, including obtaining and maintaining the following information for each Medicaid recipient:

(1) name;

(2) address;

(3) telephone number;

(4) date of birth or age;

(5) gender;